Convergence Forum 2011: Speakers so far

We're still interested in hearing your ideas for speakers and topics that we ought to include in the agenda for the 2011 Convergence Forum (May 19-21st at the Chatham Bars Inn).

We're especially looking for demonstrations of newly-launched (or prototype) consumer devices, software, or technologies of interest to participants in the pharmaceutical, healthcare, and medical device industries... so ping me at scott@nantucketconference.com if you've seen anything especially cool lately.

Here's who's on the agenda thus far:

- Katrine Bosley, CEO, Avila Therapeutics
- Michael Cima, PhD, Professor, MIT; Co-Founder, T2 Biosystems
- Michelle Dipp, MD, PhD, Senior Vice President, GSK & Partner, Longwood Founders Fund
- Sandy Fenwick, President, Children’s Hospital Boston
- Patrick Gilligan, SVP, Blue Cross Blue Shield of Mass.
- Tillman Gerngross, PhD, Founder, Adimab and GlycoFi
- Tuan Ha-Ngoc, CEO, AVEO Pharmaceuticals
- Tom Hughes, PhD, CEO, Zafgen
- Kenneth Kaitin, PhD, Director, Tufts Center for the Study of Drug Development

- Devorah Klein, Principal, Continuum
- John Maraganore, PhD, CEO, Alnylam Pharmaceuticals
- John Mendlein, PhD, Chairman, Fate Therapeutics and aTyr Pharma
- Tom McCourt, Chief Commercial Officer and Brian Cali, PhD, VP/Program Management, Ironwood Pharmaceuticals
- Greg Perry, CFO, ImmunoGen
- Todd Zion, PhD, CEO, SmartCells
- Daphne Zohar, Founder, PureTech Ventures